AdhesionGPCRs: Structure to Function | Agenda Bookshop Skip to content
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Martin Stacey
B01=Simon Yona
Category1=Non-Fiction
Category=MBGR
Category=MFGC
Category=PSBC
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€100 and above
PS=Active
softlaunch

AdhesionGPCRs: Structure to Function

English

Upon completion of the human genome project over 800 G protein-coupled receptor 1 (GPCR) genes, subdivided into five categories, were identified. These receptors sense a diverse array of stimuli, including peptides, ions, lipid analogues, light and odour, in a discriminating fashion. Subsequently, they transduce a signal from the ligandreceptor complex into numerous cellular responses. The importance of GPCRs is further reflected in the fact that they constitute the most common target for therapeutic drugs across a 2 wide range of human disorders. Phylogenetic analysis of GPCRs produced the GRAFS classification system, which subdivides GPCRs into five discrete families: glutamate, rhodopsin, adhesion, frizzled/taste2 and secretin receptors. The adhesion-GPCR family 2 can be further subdivided into eight groups. The field of adhesion-GPCR biology has indeed become large enough to require a volume dedicated solely to this field. The contributors to this book have made a courageous effort to address the key concepts of adhesion-GPCR biology, including the evolution and biochemistry of adhesion-GPCRs; there are extensive discussions on the functional nature of these receptors during development, the immune response and tumourgenesis. Finally, there are chapters dedicated to adhesion-GPCR signalling, an area of intense investigation. See more
Current price €135.84
Original price €142.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Martin StaceyB01=Simon YonaCategory1=Non-FictionCategory=MBGRCategory=MFGCCategory=PSBCCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€100 and abovePS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Dimensions: 178 x 254mm
  • Publication Date: 11 Jan 2011
  • Publisher: Springer-Verlag New York Inc.
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9781441979124

About

Simon Yona PhD graduated from Kings College University London with a BSc in Physiology and a MSc in Pharmacology before completing a PhD with Prof. R.J. Flower FRS and Prof. M. Perretti at St. Bartholomews Hospital University of London. Following his doctorate Simon took up a Postdoctoral Research position with Prof. S. Gordon FRS at the Sir William Dunn School of Pathology University of Oxford where he investigated the roles and functions of the leukocyte restricted adhesionGPCRs. Dr. Yona moved from Oxford to join the group of Prof. S. Jung at the Weizmann Institute of Science Rehovot when he was awarded a Federation of European Biochemical Societies International Fellowship. Currently he is investigating the developmental profile of mononuclear phagocytes in a number of pathologies. Martin Stacey DPhil (Oxon) graduated from Hertford College University of Oxford with an MBiochem before completing a DPhil in the laboratory of Prof. S. Gordon FRS. He continued working at the Sir William Dunn School of Pathology for a number of years where he cloned and characterized leukocyte adhesionGPCRs and demonstrated the existence of their cell surface ligands. More recently Dr. Stacey has been appointed as a Lecturer of Immunology at the University of Leeds where his laboratory focuses on adhesionGPCRs and role of myeloid cells in human disease.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept